id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02658565
|
37:58:chronic_disease
|
Preoperative evaluation to rule-out extra-uterine disease may include CT scan, MRI, or ultrasound
| 1
|
[
"Preoperative",
"evaluation",
"to",
"rule-out",
"extra-uterine",
"disease",
"may",
"include",
"CT",
"scan",
",",
"MRI",
",",
"or",
"ultrasound"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02179359
|
14:33:chronic_disease,35:46:chronic_disease,48:71:chronic_disease,95:116:chronic_disease,129:149:treatment
|
Diagnosis of Sickle Cell Disease, Thalassemia, Diamond Blackfan Anemia or other non-malignant hematologic disorders for which a stem cell transplant is indicated
| 1
|
[
"Diagnosis",
"of",
"Sickle",
"Cell",
"Disease",
",",
"Thalassemia",
",",
"Diamond",
"Blackfan",
"Anemia",
"or",
"other",
"non-malignant",
"hematologic",
"disorders",
"for",
"which",
"a",
"stem",
"cell",
"transplant",
"is",
"indicated"
] |
[
0,
0,
2,
2,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT02446457
|
15:23:chronic_disease,36:52:chronic_disease,53:58:chronic_disease
|
subjects with vitiligo or resolved childhood asthma/atopy
| 1
|
[
"subjects",
"with",
"vitiligo",
"or",
"resolved",
"childhood",
"asthma/atopy"
] |
[
0,
0,
2,
0,
0,
2,
2
] |
NCT02656706
|
20:34:treatment
|
Therapeutic use of anticoagulants
| 1
|
[
"Therapeutic",
"use",
"of",
"anticoagulants"
] |
[
0,
0,
0,
1
] |
NCT01951885
|
,,47:56:treatment
|
Total body irradiation (TBI) (≥ 1200 cGy) and etoposide (60 mg/kg)
| 1
|
[
"Total",
"body",
"irradiation",
"(",
"TBI",
")",
"(",
"≥",
"1200",
"cGy",
")",
"and",
"etoposide",
"(",
"60",
"mg/kg",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01849146
|
21:43:treatment
|
unlimited number of prior therapy regimens
| 1
|
[
"unlimited",
"number",
"of",
"prior",
"therapy",
"regimens"
] |
[
0,
0,
0,
1,
1,
1
] |
NCT03003689
|
7:26:treatment,
|
taken systemic antibiotic medications within the previous 6 months
| 1
|
[
"taken",
"systemic",
"antibiotic",
"medications",
"within",
"the",
"previous",
"6",
"months"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01849146
|
56:68:cancer,72:75:treatment,,103:112:treatment
|
measurable contrast-enhancing progressive or recurrent glioblastoma by MRI within 21 days of starting treatment
| 1
|
[
"measurable",
"contrast-enhancing",
"progressive",
"or",
"recurrent",
"glioblastoma",
"by",
"MRI",
"within",
"21",
"days",
"of",
"starting",
"treatment"
] |
[
0,
0,
0,
0,
0,
3,
0,
1,
0,
0,
0,
0,
0,
1
] |
NCT01787409
|
1:35:cancer
|
Angioimmunoblastic T-cell lymphoma
| 1
|
[
"Angioimmunoblastic",
"T-cell",
"lymphoma"
] |
[
3,
3,
3
] |
NCT02767518
|
24:38:treatment
|
Medical clearance from cardiothoracic surgeon
| 1
|
[
"Medical",
"clearance",
"from",
"cardiothoracic",
"surgeon"
] |
[
0,
0,
0,
1,
0
] |
NCT02847689
|
1:25:chronic_disease
|
Active seizure disorders
| 1
|
[
"Active",
"seizure",
"disorders"
] |
[
2,
2,
2
] |
NCT02124772
|
,,,,149:176:treatment
|
Adequate bone marrow function defined as absolute neutrophil count (ANC) >=1000/microliter, hemoglobin >=8.0 gram per deciliter (g/dL) (may receive red blood cell transfusions)
| 1
|
[
"Adequate",
"bone",
"marrow",
"function",
"defined",
"as",
"absolute",
"neutrophil",
"count",
"(",
"ANC",
")",
">",
"=1000/microliter",
",",
"hemoglobin",
">",
"=8.0",
"gram",
"per",
"deciliter",
"(",
"g/dL",
")",
"(",
"may",
"receive",
"red",
"blood",
"cell",
"transfusions",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0
] |
NCT02748070
|
1:44:chronic_disease
|
chronic rhinosinusitis with polyps (CRSwNP)
| 1
|
[
"chronic",
"rhinosinusitis",
"with",
"polyps",
"(",
"CRSwNP",
")"
] |
[
2,
2,
2,
2,
2,
0,
0
] |
NCT02577666
|
24:33:chronic_disease
|
Evidence of unremitted psychosis or other condition which would impair mother's ability to understand or participate in the intervention or consent to the research
| 1
|
[
"Evidence",
"of",
"unremitted",
"psychosis",
"or",
"other",
"condition",
"which",
"would",
"impair",
"mother",
"'s",
"ability",
"to",
"understand",
"or",
"participate",
"in",
"the",
"intervention",
"or",
"consent",
"to",
"the",
"research"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02044120
|
28:35:treatment,,58:74:treatment,,90:107:treatment,111:124:treatment
|
Time elapsed from previous therapy must be ≥ 3 weeks for systemic therapy, ≥ 2 weeks for radiation therapy or major surgery
| 1
|
[
"Time",
"elapsed",
"from",
"previous",
"therapy",
"must",
"be",
"≥",
"3",
"weeks",
"for",
"systemic",
"therapy",
",",
"≥",
"2",
"weeks",
"for",
"radiation",
"therapy",
"or",
"major",
"surgery"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1
] |
NCT02663622
|
47:81:chronic_disease
|
Patients seropositive or PCR positive for the human immunodeficiency virus (HIV)
| 1
|
[
"Patients",
"seropositive",
"or",
"PCR",
"positive",
"for",
"the",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02114229
|
44:53:chronic_disease
|
Patients who are unable to walk because of paralysis, but who are up in a wheelchair, will be considered to be ambulatory for the purpose of assessing the performance score
| 1
|
[
"Patients",
"who",
"are",
"unable",
"to",
"walk",
"because",
"of",
"paralysis",
",",
"but",
"who",
"are",
"up",
"in",
"a",
"wheelchair",
",",
"will",
"be",
"considered",
"to",
"be",
"ambulatory",
"for",
"the",
"purpose",
"of",
"assessing",
"the",
"performance",
"score"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01787409
|
25:30:cancer,34:69:cancer,99:131:treatment,133:142:treatment,143:159:treatment,161:186:treatment,188:207:treatment
|
Newly diagnosed de-novo DLBCL or primary mediastinal B-cell lymphoma that will be treated with an anthracycline-containing regimen (rituximab-cyclophosphamide, doxorubicin hydrochloride, prednisone [R-CHOP] or equivalent)
| 1
|
[
"Newly",
"diagnosed",
"de-novo",
"DLBCL",
"or",
"primary",
"mediastinal",
"B-cell",
"lymphoma",
"that",
"will",
"be",
"treated",
"with",
"an",
"anthracycline-containing",
"regimen",
"(",
"rituximab-cyclophosphamide",
",",
"doxorubicin",
"hydrochloride",
",",
"prednisone",
"[",
"R-CHOP",
"]",
"or",
"equivalent",
")"
] |
[
0,
0,
0,
3,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02674529
|
22:32:chronic_disease
|
history of resistant depression
| 1
|
[
"history",
"of",
"resistant",
"depression"
] |
[
0,
0,
0,
2
] |
NCT02857218
|
1:38:chronic_disease
|
psychiatric illness/social situations that would limit compliance with study requirements
| 1
|
[
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02408406
|
1:10:cancer,24:30:cancer,32:49:cancer,51:76:cancer
|
Malignant diagnosis in breast, gynecologic (GYN), genitourinary (GU) cancer at any stage
| 1
|
[
"Malignant",
"diagnosis",
"in",
"breast",
",",
"gynecologic",
"(",
"GYN",
")",
",",
"genitourinary",
"(",
"GU",
")",
"cancer",
"at",
"any",
"stage"
] |
[
3,
0,
0,
3,
0,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT02588326
|
1:10:chronic_disease
|
sinusitis
| 1
|
[
"sinusitis"
] |
[
2
] |
NCT02464969
|
1:24:treatment,
|
Anticoagulant treatment for the index VTE for greater than 7 days prior to randomization
| 1
|
[
"Anticoagulant",
"treatment",
"for",
"the",
"index",
"VTE",
"for",
"greater",
"than",
"7",
"days",
"prior",
"to",
"randomization"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01028846
|
22:30:chronic_disease
|
No family history of diabetes
| 1
|
[
"No",
"family",
"history",
"of",
"diabetes"
] |
[
0,
0,
0,
0,
2
] |
NCT02003222
|
68:80:treatment
|
Patients should meet the eligibility criteria for RANDOMIZATION TO BLINATUMOMAB OR NO BLINATUMOMAB-STEP 3
| 1
|
[
"Patients",
"should",
"meet",
"the",
"eligibility",
"criteria",
"for",
"RANDOMIZATION",
"TO",
"BLINATUMOMAB",
"OR",
"NO",
"BLINATUMOMAB-STEP",
"3"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02271919
|
5:12:chronic_disease,16:37:chronic_disease,39:46:chronic_disease,48:56:chronic_disease,61:83:treatment,128:137:treatment
|
Any medical or psychiatric condition, illness, disorder, or concomitant medication that could compromise participant safety or treatment, as determined by the principal investigator and/or study physician
| 1
|
[
"Any",
"medical",
"or",
"psychiatric",
"condition",
",",
"illness",
",",
"disorder",
",",
"or",
"concomitant",
"medication",
"that",
"could",
"compromise",
"participant",
"safety",
"or",
"treatment",
",",
"as",
"determined",
"by",
"the",
"principal",
"investigator",
"and/or",
"study",
"physician"
] |
[
0,
2,
0,
2,
2,
0,
2,
0,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02193932
|
54:86:treatment
|
Patients who meet the regular exclusion criteria for Magnetic Resonance Imaging (MRI) studies per the prescreening form reviewed with all patients prior to exams
| 1
|
[
"Patients",
"who",
"meet",
"the",
"regular",
"exclusion",
"criteria",
"for",
"Magnetic",
"Resonance",
"Imaging",
"(",
"MRI",
")",
"studies",
"per",
"the",
"prescreening",
"form",
"reviewed",
"with",
"all",
"patients",
"prior",
"to",
"exams"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01964859
|
16:37:chronic_disease
|
A diagnosis of uncontrolled diabetes
| 1
|
[
"A",
"diagnosis",
"of",
"uncontrolled",
"diabetes"
] |
[
0,
0,
0,
2,
2
] |
NCT02404155
|
12:27:chronic_disease
|
History of paralytic ileus
| 1
|
[
"History",
"of",
"paralytic",
"ileus"
] |
[
0,
0,
2,
2
] |
NCT02622295
|
1:21:chronic_disease
|
Deep vein thrombosis
| 1
|
[
"Deep",
"vein",
"thrombosis"
] |
[
2,
2,
2
] |
NCT02437110
|
29:40:treatment
|
History of having undergone gastrostomy at the time of screening
| 1
|
[
"History",
"of",
"having",
"undergone",
"gastrostomy",
"at",
"the",
"time",
"of",
"screening"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT00737893
|
42:50:treatment
|
The patient is taking medications called nitrates
| 1
|
[
"The",
"patient",
"is",
"taking",
"medications",
"called",
"nitrates"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02076906
|
44:53:chronic_disease
|
Patients who are unable to walk because of paralysis or motor weakness, but who are up in a wheelchair will be considered ambulatory for the purpose of calculating the performance score
| 1
|
[
"Patients",
"who",
"are",
"unable",
"to",
"walk",
"because",
"of",
"paralysis",
"or",
"motor",
"weakness",
",",
"but",
"who",
"are",
"up",
"in",
"a",
"wheelchair",
"will",
"be",
"considered",
"ambulatory",
"for",
"the",
"purpose",
"of",
"calculating",
"the",
"performance",
"score"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02163317
|
8:19:treatment,
|
Use of dutasteride within 90 days prior to registration
| 1
|
[
"Use",
"of",
"dutasteride",
"within",
"90",
"days",
"prior",
"to",
"registration"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02648282
|
28:48:chronic_disease,90:106:chronic_disease,119:143:chronic_disease,145:169:chronic_disease,171:189:chronic_disease,193:214:chronic_disease
|
Patients with uncontrolled intercurrent illness, including but not limited to ongoing or active infection, systematic congestive heart failure, unstable angina pectoris, cardiac arrhythmia or psychiatric condition that would limit compliance with study requirements
| 1
|
[
"Patients",
"with",
"uncontrolled",
"intercurrent",
"illness",
",",
"including",
"but",
"not",
"limited",
"to",
"ongoing",
"or",
"active",
"infection",
",",
"systematic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
"or",
"psychiatric",
"condition",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02203695
|
1:41:treatment
|
Primary treatment with radiation therapy
| 1
|
[
"Primary",
"treatment",
"with",
"radiation",
"therapy"
] |
[
1,
1,
1,
1,
1
] |
NCT02411656
|
44:70:treatment,66:69:treatment,87:128:treatment,123:127:treatment,189:202:cancer
|
Is HER2 normal, defined as HER2 0 or 1+ by immunohistochemistry (IHC) and negative by fluorescence in situ hybridization (FISH) if performed; or HER2 is 2+ by IHC and negative by FISH; or HER2 negative by FISH if IHC is not performed
| 1
|
[
"Is",
"HER2",
"normal",
",",
"defined",
"as",
"HER2",
"0",
"or",
"1+",
"by",
"immunohistochemistry",
"(",
"IHC",
")",
"and",
"negative",
"by",
"fluorescence",
"in",
"situ",
"hybridization",
"(",
"FISH",
")",
"if",
"performed",
";",
"or",
"HER2",
"is",
"2+",
"by",
"IHC",
"and",
"negative",
"by",
"FISH",
";",
"or",
"HER2",
"negative",
"by",
"FISH",
"if",
"IHC",
"is",
"not",
"performed"
] |
[
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02544880
|
1:20:chronic_disease,25:44:chronic_disease,60:74:treatment
|
Unilateral deafness, or severe hearing loss dependent upon hearing aid(s) for serviceable communication
| 1
|
[
"Unilateral",
"deafness",
",",
"or",
"severe",
"hearing",
"loss",
"dependent",
"upon",
"hearing",
"aid",
"(",
"s",
")",
"for",
"serviceable",
"communication"
] |
[
2,
2,
0,
0,
2,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02730481
|
,,,106:122:cancer
|
Adequate liver function as demonstrated by:Total bilirubin of ≤1.5 mg/dL or ≤2.0 mg/dL for subjects with liver metastasis
| 1
|
[
"Adequate",
"liver",
"function",
"as",
"demonstrated",
"by",
":",
"Total",
"bilirubin",
"of",
"≤1.5",
"mg/dL",
"or",
"≤2.0",
"mg/dL",
"for",
"subjects",
"with",
"liver",
"metastasis"
] |
[
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03015272
|
,93:107:treatment
|
demonstrate minimal progress in speech acquisition despite having had at least 18 months of speech therapy
| 1
|
[
"demonstrate",
"minimal",
"progress",
"in",
"speech",
"acquisition",
"despite",
"having",
"had",
"at",
"least",
"18",
"months",
"of",
"speech",
"therapy"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02321501
|
48:58:cancer,
|
Patients who have a history of another primary malignancy unless the patient has been disease free for >/= 3 years
| 1
|
[
"Patients",
"who",
"have",
"a",
"history",
"of",
"another",
"primary",
"malignancy",
"unless",
"the",
"patient",
"has",
"been",
"disease",
"free",
"for",
">",
"/=",
"3",
"years"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02086500
|
1:12:chronic_disease,,
|
Tachycardia (heart rate >110 beats per minute)
| 1
|
[
"Tachycardia",
"(",
"heart",
"rate",
">",
"110",
"beats",
"per",
"minute",
")"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01618357
|
34:41:chronic_disease,45:64:chronic_disease,116:125:treatment
|
Patients must not have a serious medical or psychiatric illness which prevents informed consent or compliance with treatment
| 1
|
[
"Patients",
"must",
"not",
"have",
"a",
"serious",
"medical",
"or",
"psychiatric",
"illness",
"which",
"prevents",
"informed",
"consent",
"or",
"compliance",
"with",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02048332
|
25:35:cancer
|
Uncontrolled relapse of malignancy
| 1
|
[
"Uncontrolled",
"relapse",
"of",
"malignancy"
] |
[
0,
0,
0,
3
] |
NCT02501096
|
,28:52:chronic_disease,,75:90:chronic_disease,92:113:chronic_disease,
|
New York Heart Association congestive heart failure of grade II or above, unstable angina, myocardial infarction within the past 6 months
| 1
|
[
"New",
"York",
"Heart",
"Association",
"congestive",
"heart",
"failure",
"of",
"grade",
"II",
"or",
"above",
",",
"unstable",
"angina",
",",
"myocardial",
"infarction",
"within",
"the",
"past",
"6",
"months"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02053909
|
,,53:74:treatment
|
Serum creatinine >1.8 mg/dL (need for contrast with CT coronary angiogram)
| 1
|
[
"Serum",
"creatinine",
">",
"1.8",
"mg/dL",
"(",
"need",
"for",
"contrast",
"with",
"CT",
"coronary",
"angiogram",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT02501473
|
80:94:cancer
|
During Patient Expansion, enrollment will be limited to relapsed or refractory follicular NHL
| 1
|
[
"During",
"Patient",
"Expansion",
",",
"enrollment",
"will",
"be",
"limited",
"to",
"relapsed",
"or",
"refractory",
"follicular",
"NHL"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02056873
|
10:53:treatment,65:79:chronic_disease,81:94:chronic_disease,96:102:chronic_disease,104:122:chronic_disease,124:145:chronic_disease,150:168:chronic_disease,230:237:treatment
|
Abnormal brain magnetic resonance imaging (MRI) scan, including severe atrophy, hydrocephalus, stroke, structural lesions, demyelinating lesions, or infectious lesions that would potentially confound the outcome or safety of the surgery as judged by the study neurosurgeon
| 1
|
[
"Abnormal",
"brain",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")",
"scan",
",",
"including",
"severe",
"atrophy",
",",
"hydrocephalus",
",",
"stroke",
",",
"structural",
"lesions",
",",
"demyelinating",
"lesions",
",",
"or",
"infectious",
"lesions",
"that",
"would",
"potentially",
"confound",
"the",
"outcome",
"or",
"safety",
"of",
"the",
"surgery",
"as",
"judged",
"by",
"the",
"study",
"neurosurgeon"
] |
[
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT01993719
|
,50:72:treatment,110:129:treatment,,227:235:chronic_disease,239:247:chronic_disease,295:310:treatment
|
More than four weeks must have elapsed since any prior systemic therapy at the time the patient receives the preparative regimen, and patients toxicities must have recovered to a grade 1 or less (except for toxicities such as alopecia or vitiligo). Patients must have progressive disease after prior treatment
| 1
|
[
"More",
"than",
"four",
"weeks",
"must",
"have",
"elapsed",
"since",
"any",
"prior",
"systemic",
"therapy",
"at",
"the",
"time",
"the",
"patient",
"receives",
"the",
"preparative",
"regimen",
",",
"and",
"patients",
"toxicities",
"must",
"have",
"recovered",
"to",
"a",
"grade",
"1",
"or",
"less",
"(",
"except",
"for",
"toxicities",
"such",
"as",
"alopecia",
"or",
"vitiligo",
")",
".",
"Patients",
"must",
"have",
"progressive",
"disease",
"after",
"prior",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02336451
|
54:69:treatment
|
Patient is receiving unstable or increasing doses of corticosteroids
| 1
|
[
"Patient",
"is",
"receiving",
"unstable",
"or",
"increasing",
"doses",
"of",
"corticosteroids"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02296684
|
1:30:treatment,37:44:treatment,50:73:treatment
|
intranasal influenza vaccines (e.g. FluMist) are live attenuated viruses
| 1
|
[
"intranasal",
"influenza",
"vaccines",
"(",
"e.g",
".",
"FluMist",
")",
"are",
"live",
"attenuated",
"viruses"
] |
[
1,
1,
1,
0,
0,
0,
1,
0,
0,
1,
1,
1
] |
NCT02519322
|
63:237:treatment,318:337:treatment,344:358:chronic_disease
|
Subjects with history of life-threatening toxicity related to prior immune therapy (e.g., anti-CTLA-4 or anti-PD-1/PD-L1 treatment or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways) except those that are unlikely to re-occur with standard countermeasures (e.g., hormone replacement after endocrinopathy)
| 1
|
[
"Subjects",
"with",
"history",
"of",
"life-threatening",
"toxicity",
"related",
"to",
"prior",
"immune",
"therapy",
"(",
"e.g.",
",",
"anti-CTLA-4",
"or",
"anti-PD-1/PD-L1",
"treatment",
"or",
"any",
"other",
"antibody",
"or",
"drug",
"specifically",
"targeting",
"T-cell",
"co-stimulation",
"or",
"immune",
"checkpoint",
"pathways",
")",
"except",
"those",
"that",
"are",
"unlikely",
"to",
"re-occur",
"with",
"standard",
"countermeasures",
"(",
"e.g.",
",",
"hormone",
"replacement",
"after",
"endocrinopathy",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
0
] |
NCT00924027
|
1:12:cancer
|
Lung cancer
| 1
|
[
"Lung",
"cancer"
] |
[
3,
3
] |
NCT03086369
|
12:59:cancer
|
Have known central nervous system malignancy or metastasis
| 1
|
[
"Have",
"known",
"central",
"nervous",
"system",
"malignancy",
"or",
"metastasis"
] |
[
0,
0,
3,
3,
3,
3,
3,
3
] |
NCT02468778
|
1:15:chronic_disease,,55:90:treatment,94:108:treatment
|
Cardiac arrest within 24 hours of procedure requiring cardiopulmonary resuscitation (CPR) or defibrillation
| 1
|
[
"Cardiac",
"arrest",
"within",
"24",
"hours",
"of",
"procedure",
"requiring",
"cardiopulmonary",
"resuscitation",
"(",
"CPR",
")",
"or",
"defibrillation"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1
] |
NCT02474199
|
12:22:cancer,
|
History of malignancy within 5 years of enrollment
| 1
|
[
"History",
"of",
"malignancy",
"within",
"5",
"years",
"of",
"enrollment"
] |
[
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT03018704
|
1:15:treatment,
|
tubal ligation or are less than two years postmenopausal
| 1
|
[
"tubal",
"ligation",
"or",
"are",
"less",
"than",
"two",
"years",
"postmenopausal"
] |
[
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02807272
|
19:76:treatment
|
Concurrent use of granulocyte macrophage colony-stimulating factor (GM-CSF)
| 1
|
[
"Concurrent",
"use",
"of",
"granulocyte",
"macrophage",
"colony-stimulating",
"factor",
"(",
"GM-CSF",
")"
] |
[
0,
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02669966
|
22:34:chronic_disease,22:25:chronic_disease,82:94:chronic_disease,98:101:treatment
|
The recipient may be HCV antibody negative or anti-HCV antibody positive but HCV RNA negative by PCR
| 1
|
[
"The",
"recipient",
"may",
"be",
"HCV",
"antibody",
"negative",
"or",
"anti-HCV",
"antibody",
"positive",
"but",
"HCV",
"RNA",
"negative",
"by",
"PCR"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
1
] |
NCT02578641
|
10:21:chronic_disease
|
Positive hepatitis B surface antigen (HBsAg) results
| 1
|
[
"Positive",
"hepatitis",
"B",
"surface",
"antigen",
"(",
"HBsAg",
")",
"results"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02105766
|
8:16:chronic_disease,20:32:treatment
|
portal fibrosis by liver biopsy
| 1
|
[
"portal",
"fibrosis",
"by",
"liver",
"biopsy"
] |
[
0,
2,
0,
1,
1
] |
NCT02349867
|
1:15:treatment
|
Anticoagulants at therapeutic doses
| 1
|
[
"Anticoagulants",
"at",
"therapeutic",
"doses"
] |
[
1,
0,
0,
0
] |
NCT02225548
|
,11:20:treatment,
|
an IIEF-5 tadalafil-alone baseline score that is ≤ 18
| 1
|
[
"an",
"IIEF-5",
"tadalafil-alone",
"baseline",
"score",
"that",
"is",
"≤",
"18"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT03156543
|
29:50:treatment
|
Limited to total or reverse shoulder arthroplasty
| 1
|
[
"Limited",
"to",
"total",
"or",
"reverse",
"shoulder",
"arthroplasty"
] |
[
0,
0,
0,
0,
0,
1,
1
] |
NCT01532687
|
1:18:treatment,20:27:treatment,31:49:treatment
|
Radiation therapy, surgery or tumor embolization
| 1
|
[
"Radiation",
"therapy",
",",
"surgery",
"or",
"tumor",
"embolization"
] |
[
1,
1,
0,
1,
0,
1,
1
] |
NCT02824276
|
1:5:chronic_disease,
|
CLBP lasting for more than 6 months as the primary complaint
| 1
|
[
"CLBP",
"lasting",
"for",
"more",
"than",
"6",
"months",
"as",
"the",
"primary",
"complaint"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02478684
|
15:30:chronic_disease
|
Bleeding from placenta previa
| 1
|
[
"Bleeding",
"from",
"placenta",
"previa"
] |
[
0,
0,
2,
2
] |
NCT02770547
|
1:38:chronic_disease
|
Chronic Obstructive Pulmonary Disease
| 1
|
[
"Chronic",
"Obstructive",
"Pulmonary",
"Disease"
] |
[
2,
2,
2,
2
] |
NCT02996227
|
26:44:treatment,
|
Expected requirement for parenteral opioids for at least 72 hours for postoperative pain
| 1
|
[
"Expected",
"requirement",
"for",
"parenteral",
"opioids",
"for",
"at",
"least",
"72",
"hours",
"for",
"postoperative",
"pain"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02474667
|
10:46:treatment,48:61:treatment,69:80:treatment
|
Requires treatment with the CYP1A2 inhibitors, ciprofloxacin and/or fluvoxamine
| 1
|
[
"Requires",
"treatment",
"with",
"the",
"CYP1A2",
"inhibitors",
",",
"ciprofloxacin",
"and/or",
"fluvoxamine"
] |
[
0,
1,
1,
1,
1,
1,
0,
1,
0,
1
] |
NCT01959698
|
,,,,,125:134:treatment
|
Serum creatinine of =< 1.5 mg/dL; if creatinine > 1.5 mg/dL creatinine clearance must be > 60 mL/min within 7 days prior to treatment either measured or calculated using a standard Cockcroft and Gault formula
| 1
|
[
"Serum",
"creatinine",
"of",
"=",
"<",
"1.5",
"mg/dL",
";",
"if",
"creatinine",
">",
"1.5",
"mg/dL",
"creatinine",
"clearance",
"must",
"be",
">",
"60",
"mL/min",
"within",
"7",
"days",
"prior",
"to",
"treatment",
"either",
"measured",
"or",
"calculated",
"using",
"a",
"standard",
"Cockcroft",
"and",
"Gault",
"formula"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02433626
|
1:14:treatment,26:101:treatment,,140:146:treatment
|
Major surgery, excluding skin biopsies and procedures for insertion of central venous access devices, within 28 days prior to the start of COTI-2
| 1
|
[
"Major",
"surgery",
",",
"excluding",
"skin",
"biopsies",
"and",
"procedures",
"for",
"insertion",
"of",
"central",
"venous",
"access",
"devices",
",",
"within",
"28",
"days",
"prior",
"to",
"the",
"start",
"of",
"COTI-2"
] |
[
1,
1,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02776891
|
1:6:cancer
|
DLBCL without myc translocation or overexpression by the above methods
| 1
|
[
"DLBCL",
"without",
"myc",
"translocation",
"or",
"overexpression",
"by",
"the",
"above",
"methods"
] |
[
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01894061
|
20:54:chronic_disease,50:53:chronic_disease,55:64:chronic_disease
|
Known diagnosis of human immunodeficiency virus (HIV) infection (HIV testing is not mandatory)
| 1
|
[
"Known",
"diagnosis",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection",
"(",
"HIV",
"testing",
"is",
"not",
"mandatory",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03176979
|
,23:31:treatment,33:40:treatment,45:62:treatment,67:80:cancer
|
Women with history of surgical, medical, or radiation therapy for breast cancer
| 1
|
[
"Women",
"with",
"history",
"of",
"surgical",
",",
"medical",
",",
"or",
"radiation",
"therapy",
"for",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
0,
3,
3
] |
NCT03023449
|
1:22:chronic_disease
|
Acute ischemic stroke in the territory of the anterior, middle, or posterior cerebral artery, on either side of the brain
| 1
|
[
"Acute",
"ischemic",
"stroke",
"in",
"the",
"territory",
"of",
"the",
"anterior",
",",
"middle",
",",
"or",
"posterior",
"cerebral",
"artery",
",",
"on",
"either",
"side",
"of",
"the",
"brain"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01495819
|
36:59:treatment,61:76:treatment,78:92:treatment,97:108:treatment,139:148:treatment,153:174:chronic_disease,185:201:chronic_disease,203:219:chronic_disease,221:234:chronic_disease
|
requirement of any form of regular psychotropic medication (antidepressants, antipsychotics, or anxiolytics) or psychiatric diagnosis and treatment for psychiatric disorders including major depression, bipolar disorder, schizophrenia in the past 6 months
| 1
|
[
"requirement",
"of",
"any",
"form",
"of",
"regular",
"psychotropic",
"medication",
"(",
"antidepressants",
",",
"antipsychotics",
",",
"or",
"anxiolytics",
")",
"or",
"psychiatric",
"diagnosis",
"and",
"treatment",
"for",
"psychiatric",
"disorders",
"including",
"major",
"depression",
",",
"bipolar",
"disorder",
",",
"schizophrenia",
"in",
"the",
"past",
"6",
"months"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
1,
0,
0,
2,
2,
0,
1,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0
] |
NCT02309580
|
16:41:chronic_disease
|
without active graft-versus-host-disease
| 1
|
[
"without",
"active",
"graft-versus-host-disease"
] |
[
0,
0,
2
] |
NCT01722240
|
12:24:chronic_disease
|
history of pancreatitis
| 1
|
[
"history",
"of",
"pancreatitis"
] |
[
0,
0,
2
] |
NCT02464696
|
1:6:chronic_disease
|
Shock
| 1
|
[
"Shock"
] |
[
2
] |
NCT02222545
|
6:14:chronic_disease
|
Have STEC-HUS
| 1
|
[
"Have",
"STEC-HUS"
] |
[
0,
2
] |
NCT02555280
|
64:68:chronic_disease,70:73:chronic_disease,82:91:chronic_disease
|
Known or documented history of communicable disease, including AIDS, HIV, active Hepatitis
| 1
|
[
"Known",
"or",
"documented",
"history",
"of",
"communicable",
"disease",
",",
"including",
"AIDS",
",",
"HIV",
",",
"active",
"Hepatitis"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2
] |
NCT02105766
|
1:21:chronic_disease,31:34:chronic_disease,53:64:treatment,
|
Acute chest syndrome/ 2 prior ACS/ any ACS while on hydroxyurea (at MTD for at least 6 months)
| 1
|
[
"Acute",
"chest",
"syndrome/",
"2",
"prior",
"ACS/",
"any",
"ACS",
"while",
"on",
"hydroxyurea",
"(",
"at",
"MTD",
"for",
"at",
"least",
"6",
"months",
")"
] |
[
2,
2,
2,
0,
0,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02572856
|
1:9:chronic_disease,,,,
|
diabetic (both Type 1 & 2) patients who are self-monitoring glucose levels (via finger stick measurements) two to three times daily
| 1
|
[
"diabetic",
"(",
"both",
"Type",
"1",
"&",
"2",
")",
"patients",
"who",
"are",
"self-monitoring",
"glucose",
"levels",
"(",
"via",
"finger",
"stick",
"measurements",
")",
"two",
"to",
"three",
"times",
"daily"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02536794
|
97:110:cancer,,,
|
Patients must have a histologically documented (either primary or metastatic site) diagnosis of breast cancer that is HER2 non-overexpressing by immunohistochemistry, namely 0 or 1
| 1
|
[
"Patients",
"must",
"have",
"a",
"histologically",
"documented",
"(",
"either",
"primary",
"or",
"metastatic",
"site",
")",
"diagnosis",
"of",
"breast",
"cancer",
"that",
"is",
"HER2",
"non-overexpressing",
"by",
"immunohistochemistry",
",",
"namely",
"0",
"or",
"1"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02408861
|
,,,,,,283:319:treatment,321:353:treatment,358:366:treatment
|
Participants must have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as >= 20 mm with conventional techniques or as >= 10 mm with spiral computed tomography (CT) scan, magnetic resonance imaging (MRI), or calipers by clinical exam
| 1
|
[
"Participants",
"must",
"have",
"measurable",
"disease",
",",
"defined",
"as",
"at",
"least",
"one",
"lesion",
"that",
"can",
"be",
"accurately",
"measured",
"in",
"at",
"least",
"one",
"dimension",
"(",
"longest",
"diameter",
"to",
"be",
"recorded",
"for",
"non-nodal",
"lesions",
"and",
"short",
"axis",
"for",
"nodal",
"lesions",
")",
"as",
">",
"=",
"20",
"mm",
"with",
"conventional",
"techniques",
"or",
"as",
">",
"=",
"10",
"mm",
"with",
"spiral",
"computed",
"tomography",
"(",
"CT",
")",
"scan",
",",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")",
",",
"or",
"calipers",
"by",
"clinical",
"exam"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT03146663
|
16:31:chronic_disease,58:74:chronic_disease,85:99:treatment
|
Presence of an serious illness, uncontrolled illness, or active infection requiring IV antibiotics
| 1
|
[
"Presence",
"of",
"an",
"serious",
"illness",
",",
"uncontrolled",
"illness",
",",
"or",
"active",
"infection",
"requiring",
"IV",
"antibiotics"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1
] |
NCT02519543
|
13:26:chronic_disease
|
presence of rapid cycling (by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5 criteria)
| 1
|
[
"presence",
"of",
"rapid",
"cycling",
"(",
"by",
"the",
"Diagnostic",
"and",
"Statistical",
"Manual",
"of",
"Mental",
"Disorders",
"(",
"DSM-5",
"criteria",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02383927
|
34:47:treatment
|
has relapsed or is refractory to prior therapy
| 1
|
[
"has",
"relapsed",
"or",
"is",
"refractory",
"to",
"prior",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02494258
|
23:32:treatment,38:66:treatment,81:107:treatment
|
subject is tolerating treatment with oral azacitidine monotherapy and continued oral azacitidine treatment
| 1
|
[
"subject",
"is",
"tolerating",
"treatment",
"with",
"oral",
"azacitidine",
"monotherapy",
"and",
"continued",
"oral",
"azacitidine",
"treatment"
] |
[
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02446093
|
23:32:allergy_name
|
allergic reactions to acyclovir
| 1
|
[
"allergic",
"reactions",
"to",
"acyclovir"
] |
[
0,
0,
0,
4
] |
NCT01811368
|
1:20:chronic_disease
|
Alcoholic hepatitis
| 1
|
[
"Alcoholic",
"hepatitis"
] |
[
2,
2
] |
NCT01379573
|
15:38:chronic_disease
|
developmental tricuspid valve disease
| 1
|
[
"developmental",
"tricuspid",
"valve",
"disease"
] |
[
0,
2,
2,
2
] |
NCT02019940
|
1:23:chronic_disease,
|
Substance use disorder during the 3 months prior to screening; except for Cannabis and Alcohol use Disorders
| 1
|
[
"Substance",
"use",
"disorder",
"during",
"the",
"3",
"months",
"prior",
"to",
"screening",
";",
"except",
"for",
"Cannabis",
"and",
"Alcohol",
"use",
"Disorders"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00914628
|
1:4:cancer,9:12:cancer,34:36:treatment
|
AML and ALL in 2nd or subsequent CR
| 1
|
[
"AML",
"and",
"ALL",
"in",
"2nd",
"or",
"subsequent",
"CR"
] |
[
3,
0,
3,
0,
0,
0,
0,
1
] |
NCT02311361
|
43:55:treatment,
|
Subjects, if enrolled, should not receive live vaccine during the study and 180 days after the last dose of both drugs
| 1
|
[
"Subjects",
",",
"if",
"enrolled",
",",
"should",
"not",
"receive",
"live",
"vaccine",
"during",
"the",
"study",
"and",
"180",
"days",
"after",
"the",
"last",
"dose",
"of",
"both",
"drugs"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02901041
|
18:30:allergy_name
|
Known allergy to sulfonamides
| 1
|
[
"Known",
"allergy",
"to",
"sulfonamides"
] |
[
0,
0,
0,
4
] |
NCT01099644
|
5:11:cancer,23:28:cancer,30:38:treatment
|
For tumors other than DSRCT, Burtomab reactivity must be confirmed by immunohistochemistry
| 1
|
[
"For",
"tumors",
"other",
"than",
"DSRCT",
",",
"Burtomab",
"reactivity",
"must",
"be",
"confirmed",
"by",
"immunohistochemistry"
] |
[
0,
3,
0,
0,
3,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02498613
|
,74:83:treatment
|
A New York Heart Association (NYHA) classification of II controlled with treatment
| 1
|
[
"A",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"classification",
"of",
"II",
"controlled",
"with",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02100891
|
1:4:chronic_disease
|
HIV-positive donors
| 1
|
[
"HIV-positive",
"donors"
] |
[
2,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.